丙酚替诺福韦 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "丙酚替诺福韦" in Chinese language version.

refsWebsite

Global rank Chinese rank

12web.archive.org

1^st place

4nih.gov

4^th place

5^th place

3fda.gov

447^th place

581^st place

2europa.eu

68^th place

209^th place

1drugs.com

399^th place

208^th place

1medicines.org.uk

3,823^rd place

3,456^th place

1doi.org

2^nd place

23^rd place

1hhs.gov

5,973^rd place

7,636^th place

1nytimes.com

7^th place

31^st place

1tga.gov.au

3,984^th place

1,603^rd place

doi.org

Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood. Nucleosides Nucleotides Nucleic Acids. 2001, 20 (4–7): 1091–8. PMID 11562963. doi:10.1081/NCN-100002496.

drugs.com

Tenofovir alafenamide (Vemlidy) Use During Pregnancy. Drugs.com. 26 December 2018 [18 April 2020]. （原始内容存档于2021-07-09）.

europa.eu

ema.europa.eu

Vemlidy EPAR. European Medicines Agency (EMA). [2021-07-01]. （原始内容存档于2021-07-13）.
Symtuza EPAR. European Medicines Agency. [19 August 2020]. （原始内容存档于2021-07-10）.

fda.gov

accessdata.fda.gov

Drug Approval Package: Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide). U.S. Food and Drug Administration (FDA). 11 December 2018 [19 August 2020]. （原始内容存档于2021-07-09）.
Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [5 December 2020]. （原始内容存档于2021-07-09）.

fda.gov

FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. U.S. Food and Drug Administration (FDA). 3 October 2019 [11 October 2019]. （原始内容存档于11 October 2019）.

hhs.gov

FDA Approves Vemlidy (tenofovir alafenamide) for Chronic Hepatitis B in Adults. United States Department of Health and Human Services. 21 November 2016 [11 October 2019]. （原始内容存档于11 October 2019）.

medicines.org.uk

Vemlidy 25 mg film coated tablets - Summary of Product Characteristics (SmPC). (emc). 8 September 2020 [12 November 2020]. （原始内容存档于2021-07-11）.

nih.gov

dailymed.nlm.nih.gov

Vemlidy- tenofovir alafenamide tablet. DailyMed. 11 February 2020 [18 April 2020]. （原始内容存档于2021-07-09）.
Descovy- emtricitabine and tenofovir alafenamide tablet. DailyMed. 13 January 2020 [18 April 2020]. （原始内容存档于2021-06-24）.
Symtuza- darunavir, cobicistat, emtricitabine, and tenofovir alafenamide tablet, film coated. DailyMed. 6 March 2020 [18 April 2020]. （原始内容存档于2021-07-09）.

ncbi.nlm.nih.gov

Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood. Nucleosides Nucleotides Nucleic Acids. 2001, 20 (4–7): 1091–8. PMID 11562963. doi:10.1081/NCN-100002496.

nytimes.com

Mandavilli, Apoorva. F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Everyone. The New York Times. 4 October 2019 [11 October 2019]. （原始内容存档于2021-07-09）.

tga.gov.au

ebs.tga.gov.au

http://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=CCE11C6BC5177A30CA2585AE00423857&agid=(PrintDetailsPublic)&actionid=1^{[失效連結]}

web.archive.org

Tenofovir alafenamide (Vemlidy) Use During Pregnancy. Drugs.com. 26 December 2018 [18 April 2020]. （原始内容存档于2021-07-09）.
Vemlidy 25 mg film coated tablets - Summary of Product Characteristics (SmPC). (emc). 8 September 2020 [12 November 2020]. （原始内容存档于2021-07-11）.
Vemlidy- tenofovir alafenamide tablet. DailyMed. 11 February 2020 [18 April 2020]. （原始内容存档于2021-07-09）.
Vemlidy EPAR. European Medicines Agency (EMA). [2021-07-01]. （原始内容存档于2021-07-13）.
FDA Approves Vemlidy (tenofovir alafenamide) for Chronic Hepatitis B in Adults. United States Department of Health and Human Services. 21 November 2016 [11 October 2019]. （原始内容存档于11 October 2019）.
Descovy- emtricitabine and tenofovir alafenamide tablet. DailyMed. 13 January 2020 [18 April 2020]. （原始内容存档于2021-06-24）.
FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. U.S. Food and Drug Administration (FDA). 3 October 2019 [11 October 2019]. （原始内容存档于11 October 2019）.
Mandavilli, Apoorva. F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Everyone. The New York Times. 4 October 2019 [11 October 2019]. （原始内容存档于2021-07-09）.
Symtuza- darunavir, cobicistat, emtricitabine, and tenofovir alafenamide tablet, film coated. DailyMed. 6 March 2020 [18 April 2020]. （原始内容存档于2021-07-09）.
Drug Approval Package: Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide). U.S. Food and Drug Administration (FDA). 11 December 2018 [19 August 2020]. （原始内容存档于2021-07-09）.
Symtuza EPAR. European Medicines Agency. [19 August 2020]. （原始内容存档于2021-07-10）.
Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA). [5 December 2020]. （原始内容存档于2021-07-09）.